Instil Bio, Inc. (TIL)

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019
Cash & Equivalents	43.72	37.59	241.71	8.9
Short-Term Investments	217.2	416.51	0	0
Cash & Cash Equivalents	260.92	454.1	241.71	8.9
Cash Growth	-42.54%	87.87%	2617.41%	-
Other Current Assets	8.46	9.92	4.42	0.39
Total Current Assets	269.38	464.02	246.14	9.29
Property, Plant & Equipment	209.34	122	55.34	0.19
Goodwill and Intangibles	0	15.83	15.83	0
Other Long-Term Assets	3.41	8.14	1.71	0
Total Long-Term Assets	212.75	145.96	72.87	0.19
Total Assets	482.13	609.98	319.01	9.48
Accounts Payable	2.36	5.57	3.5	0.98
Other Current Liabilities	30.43	35.79	9.79	0.44
Total Current Liabilities	32.79	41.36	13.28	1.42
Long-Term Debt	77.52	0	0	0
Other Long-Term Liabilities	8.21	13.43	13.36	0
Total Long-Term Liabilities	85.74	13.43	13.36	0
Total Liabilities	118.52	54.78	26.65	1.42
Total Debt	77.52	0	0	0
Common Stock	788.99	757	5.61	0.29
Retained Earnings	-424.89	-201.72	-44.92	-7.19
Comprehensive Income	-0.49	-0.09	-0.28	0
Shareholders' Equity	363.61	555.2	-39.6	-6.89
Net Cash / Debt	183.4	454.1	241.71	8.9
Net Cash / Debt Growth	-59.61%	87.87%	2617.41%	-
Net Cash Per Share	28.32	85.68	302.18	15.02
Working Capital	236.59	422.66	232.86	7.87
Book Value Per Share	56.15	104.76	-49.51	-11.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).